102 related articles for article (PubMed ID: 28422200)
1. Enhancing MRI of liver metastases with a zwitterionized biodegradable dendritic contrast agent.
Zhou X; Ye M; Han Y; Tang J; Qian Y; Hu H; Shen Y
Biomater Sci; 2017 Jul; 5(8):1588-1595. PubMed ID: 28422200
[TBL] [Abstract][Full Text] [Related]
2. Targeted biodegradable dendritic MRI contrast agent for enhanced tumor imaging.
Ye M; Qian Y; Tang J; Hu H; Sui M; Shen Y
J Control Release; 2013 Aug; 169(3):239-45. PubMed ID: 23403397
[TBL] [Abstract][Full Text] [Related]
3. Gadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agents.
Luo K; Liu G; She W; Wang Q; Wang G; He B; Ai H; Gong Q; Song B; Gu Z
Biomaterials; 2011 Nov; 32(31):7951-60. PubMed ID: 21784511
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of Chiral Dendrimer-Triamine-Coordinated Gd-MRI Contrast Agents Evaluated by in Vivo MRI and Estimated by in Vitro QCM.
Miyake Y; Ishikawa S; Kimura Y; Son A; Imai H; Matsuda T; Yamada H; Toshimitsu A; Kondo T
Sensors (Basel); 2015 Dec; 15(12):31973-86. PubMed ID: 26694418
[TBL] [Abstract][Full Text] [Related]
5. New nanosized biocompatible MR contrast agents based on lysine-dendri-graft macromolecules.
Ogawa M; Regino CA; Marcelino B; Williams M; Kosaka N; Bryant LH; Choyke PL; Kobayashi H
Bioconjug Chem; 2010 May; 21(5):955-60. PubMed ID: 20235572
[TBL] [Abstract][Full Text] [Related]
6. Development of a dendritic manganese-enhanced magnetic resonance imaging (MEMRI) contrast agent: synthesis, toxicity (in vitro) and relaxivity (in vitro, in vivo) studies.
Bertin A; Steibel J; Michou-Gallani AI; Gallani JL; Felder-Flesch D
Bioconjug Chem; 2009 Apr; 20(4):760-7. PubMed ID: 19368343
[TBL] [Abstract][Full Text] [Related]
7. A Hyaluronic Acid-Conjugated Gadolinium Hepatocyte-Specific T1 Contrast Agent for Liver Magnetic Resonance Imaging.
Moon M; Thomas RG; Heo SU; Park MS; Bae WK; Heo SH; Yim NY; Jeong YY
Mol Imaging Biol; 2015 Aug; 17(4):497-503. PubMed ID: 25604386
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable Nanoglobular Magnetic Resonance Imaging Contrast Agent Constructed with Host-Guest Self-Assembly for Tumor-Targeted Imaging.
Cao Y; Zu G; Kuang Y; He Y; Mao Z; Liu M; Xiong D; Pei R
ACS Appl Mater Interfaces; 2018 Aug; 10(32):26906-26916. PubMed ID: 30028584
[TBL] [Abstract][Full Text] [Related]
10. [MR imaging of liver metastasis using Gd-EOB-DTPA].
Kuwatsuru R
Gan To Kagaku Ryoho; 2009 Aug; 36(8):1234-41. PubMed ID: 19692760
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of gadolinium complexes based on PAMAM as MRI contrast agents.
Yan GP; Hu B; Liu ML; Li LY
J Pharm Pharmacol; 2005 Mar; 57(3):351-7. PubMed ID: 15807991
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional gadolinium-based dendritic macromolecules as liver targeting imaging probes.
Luo K; Liu G; He B; Wu Y; Gong Q; Song B; Ai H; Gu Z
Biomaterials; 2011 Apr; 32(10):2575-85. PubMed ID: 21256587
[TBL] [Abstract][Full Text] [Related]
13. Peptide-conjugated polyamidoamine dendrimer as a nanoscale tumor-targeted T1 magnetic resonance imaging contrast agent.
Han L; Li J; Huang S; Huang R; Liu S; Hu X; Yi P; Shan D; Wang X; Lei H; Jiang C
Biomaterials; 2011 Apr; 32(11):2989-98. PubMed ID: 21277017
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium-loaded polymeric nanoparticles modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer.
Liu Y; Chen Z; Liu C; Yu D; Lu Z; Zhang N
Biomaterials; 2011 Aug; 32(22):5167-76. PubMed ID: 21521627
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
[TBL] [Abstract][Full Text] [Related]
16. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores.
Kobayashi H; Kawamoto S; Jo SK; Bryant HL; Brechbiel MW; Star RA
Bioconjug Chem; 2003; 14(2):388-94. PubMed ID: 12643749
[TBL] [Abstract][Full Text] [Related]
17. Hydrothermally synthesized PEGylated calcium phosphate nanoparticles incorporating Gd-DTPA for contrast enhanced MRI diagnosis of solid tumors.
Mi P; Kokuryo D; Cabral H; Kumagai M; Nomoto T; Aoki I; Terada Y; Kishimura A; Nishiyama N; Kataoka K
J Control Release; 2014 Jan; 174():63-71. PubMed ID: 24211705
[TBL] [Abstract][Full Text] [Related]
18. Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
Mühler A; Clément O; Vexler V; Berthezène Y; Rosenau W; Brasch RC
Radiology; 1992 Jul; 184(1):207-13. PubMed ID: 1609081
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging of osteosarcoma using a bis(alendronate)-based bone-targeted contrast agent.
Ge P; Sheng F; Jin Y; Tong L; Du L; Zhang L; Tian N; Li G
Biomed Pharmacother; 2016 Dec; 84():423-429. PubMed ID: 27682736
[TBL] [Abstract][Full Text] [Related]
20. Gd-DTPA L-cystine bisamide copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging.
Kaneshiro TL; Ke T; Jeong EK; Parker DL; Lu ZR
Pharm Res; 2006 Jun; 23(6):1285-94. PubMed ID: 16729223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
